This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1970 May;125(5):825-9.

doi: 10.1001/archinte.125.5.825.

Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon

S G Romeo, R E Whalen, J P Tindall

PMID: 5444311
DOI: 10.1001/archinte.125.5.825

Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon

S G Romeo et al. Arch Intern Med. 1970 May.

. 1970 May;125(5):825-9.

doi: 10.1001/archinte.125.5.825.

Authors

S G Romeo, R E Whalen, J P Tindall

PMID: 5444311
DOI: 10.1001/archinte.125.5.825

No abstract available

PubMed Disclaimer

Similar articles

Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
Surwit RS, Gilgor RS, Duvic M, Allen LM, Neal JA. Surwit RS, et al. Arch Dermatol. 1983 Sep;119(9):733-5. Arch Dermatol. 1983. PMID: 6614959 Clinical Trial.
[Intra-arterial reserpine in Raynaud's disease and syndrome].
Arcas Meca R, Ono Okabe S, Barroso-Moguel R, Quijano Pitman F. Arcas Meca R, et al. Arch Inst Cardiol Mex. 1972 Mar-Apr;42(2):260-8. Arch Inst Cardiol Mex. 1972. PMID: 5028993 Spanish. No abstract available.
Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.
Willerson JT, Thompson RH, Hookman P, Herdt J, Decker JL. Willerson JT, et al. Ann Intern Med. 1970 Jan;72(1):17-27. doi: 10.7326/0003-4819-72-1-17. Ann Intern Med. 1970. PMID: 5410395 No abstract available.
Raynaud's phenomenon: its relevance to scleroderma.
Belch JJ. Belch JJ. Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):839-45. doi: 10.1136/ard.50.suppl_4.839. Ann Rheum Dis. 1991. PMID: 1750795 Free PMC article. Review. No abstract available.
Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Henness S, Wigley FM. Henness S, et al. Curr Opin Rheumatol. 2007 Nov;19(6):611-8. doi: 10.1097/BOR.0b013e3282f13137. Curr Opin Rheumatol. 2007. PMID: 17917543 Review.

See all similar articles

Cited by

Prostaglandin E1 therapy for digital ulcers in scleroderma.
Baron M, Skrinskas G, Urowitz MB, Madras PN. Baron M, et al. Can Med Assoc J. 1982 Jan 1;126(1):42-5. Can Med Assoc J. 1982. PMID: 7199370 Free PMC article. No abstract available.
Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
Nilsen KH, Jayson MI. Nilsen KH, et al. Br Med J. 1980 Jun 14;280(6229):1408-11. doi: 10.1136/bmj.280.6229.1408. Br Med J. 1980. PMID: 7427134 Free PMC article.
Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.
Nolph KD, Miller L, Husted FC, Hirszel P. Nolph KD, et al. Int Urol Nephrol. 1976;8(2):161-9. doi: 10.1007/BF02082213. Int Urol Nephrol. 1976. PMID: 965210
Effect of low dose intra-arterial reserpine on vascular wall norepinephrine content.
Porter JM, Reiney CG. Porter JM, et al. Ann Surg. 1975 Jul;182(1):50-5. doi: 10.1097/00000658-197507000-00010. Ann Surg. 1975. PMID: 1147709 Free PMC article.
Reserpine treatment of Raynaud's disease.
Nobin BA, Nielsen SL, Eklov B, Lassen NA. Nobin BA, et al. Ann Surg. 1978 Jan;187(1):12-6. doi: 10.1097/00000658-197801000-00003. Ann Surg. 1978. PMID: 619795 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems